Touchon Pascal (CIK 0001780060)

Latest company ownership

ATRA - Atara Biotherapeutics, Inc.

Role: CEO

Shares held

77,955

Last filed at

Jun 12, 2025

Confidence Score

50.0

2025Q4

Confidence Score History

2020Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Aug 16, 2024	Aug 20, 2024	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-3,038	-4.15%	✗	$20.1K
May 16, 2024	May 20, 2024	Atara Biotherapeutics, Inc.	CEO	Sell	42.5	-81,506	-4.27%	✗	$50.3K
Mar 4, 2024	Mar 6, 2024	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-24,844	-1.28%	✗	$17.9K
Nov 16, 2023	Nov 20, 2023	Atara Biotherapeutics, Inc.	CEO	Sell	47.5	-20,409	-3.02%	✗	$7.9K
Aug 16, 2023	Aug 18, 2023	Atara Biotherapeutics, Inc.	CEO	Sell	42.5	-30,766	-4.35%	✗	$50.8K
Jun 27, 2023	Jun 29, 2023	Atara Biotherapeutics, Inc.	CEO	Sell	46.3	-14,291	-1.98%	✗	$23.7K
May 16, 2023	May 18, 2023	Atara Biotherapeutics, Inc.	CEO	Sell	42.5	-29,766	-3.96%	✗	$60.6K
Mar 2, 2023	Mar 6, 2023	Atara Biotherapeutics, Inc.	CEO	Sell	41.3	-15,679	-2.05%	✓	$56.9K
Nov 16, 2022	Nov 18, 2022	Atara Biotherapeutics, Inc.	CEO	Sell	37.5	-15,591	-3.41%	✓	$70K
Aug 16, 2022	Aug 18, 2022	Atara Biotherapeutics, Inc.	CEO	Sell	37.5	-14,806	-3.14%	✓	$74.5K
Jun 27, 2022	Jun 29, 2022	Atara Biotherapeutics, Inc.	CEO	Sell	41.3	-14,220	-2.92%	✓	$102.4K
May 17, 2022	May 19, 2022	Atara Biotherapeutics, Inc.	CEO	Sell	41.3	-13,913	-2.78%	✓	$74K
Mar 1, 2022	Mar 3, 2022	Atara Biotherapeutics, Inc.	CEO	Sell	95.0	+171,737	52.28%	✓	$87K
Nov 16, 2021	Nov 18, 2021	Atara Biotherapeutics, Inc.	CEO	Sell	41.3	-8,402	-2.49%	✓	$143.8K
Aug 17, 2021	Aug 19, 2021	Atara Biotherapeutics, Inc.	CEO	Sell	41.3	-8,223	-2.38%	✓	$103.1K
Jun 25, 2021	Jun 29, 2021	Atara Biotherapeutics, Inc.	CEO	Sell	37.5	-14,194	-3.95%	✓	$231.7K
May 18, 2021	May 20, 2021	Atara Biotherapeutics, Inc.	CEO	Sell	41.3	-8,313	-2.26%	✓	$121K
Mar 2, 2021	Mar 4, 2021	Atara Biotherapeutics, Inc.	CEO	Sell	45.0	-4,887	-1.31%	✓	$81.8K
Nov 17, 2020	Nov 18, 2020	Atara Biotherapeutics, Inc.	CEO	Sell	45.0	-4,716	-1.81%	✓	$93.3K
Aug 18, 2020	Aug 20, 2020	Atara Biotherapeutics, Inc.	CEO	Sell	45.0	-4,807	-1.82%	✓	$58.1K
Jun 25, 2020	Jun 26, 2020	Atara Biotherapeutics, Inc.	CEO	Sell	37.5	-12,135	-4.38%	✓	$156.8K
May 18, 2020	May 20, 2020	Atara Biotherapeutics, Inc.	CEO	Sell	48.8	-3,195	-1.14%	✓	$35.8K
Jan 24, 2020	Jan 28, 2020	Atara Biotherapeutics, Inc.	CEO	Sell	22.5	-9,900	-7.07%	✗	$134.8K